AngioDynamics ANGO Med Device — Gross Margin %

Similar metrics at other companies

AORTMedical devices — Total gross margin

$61.75M+15.3%

MDTGross Profit

$6.41B+10.9%

AVAHMedical Solutions — Gross Margin Percentage

44.7%+2.0pp

BDXMedical — Cost of Products Sold as a Percent of Revenues

11.9%-0.5pp

ABTGross Profit

$6.27B+6.5%

VREXMedical — Gross Profit

$50.6M-9.5%

Questions, answered.

What is AngioDynamics's med device — gross margin %?

AngioDynamics (ANGO) reported med device — gross margin % of 44.2% in Q4 2025.

How has AngioDynamics's med device — gross margin % changed year-over-year?

AngioDynamics's med device — gross margin % decreased by 6.8% year-over-year, from 47.4% to 44.2%.

What is the long-term trend for AngioDynamics's med device — gross margin %?

Over 2 years (2021 to 2024), AngioDynamics's med device — gross margin % has grown at a 62.2% compound annual growth rate (CAGR), from 49.8% to 131%.

What does med device — gross margin % mean?

Gross margin percentage represents the proportion of net sales that remains after deducting the direct costs of goods sold for the medical device segment. It is a key measure of pricing power and manufacturing efficiency, indicating how much of every dollar earned is available to cover operating expenses. Higher margins generally suggest a competitive advantage in product pricing or superior cost management in the medical device market.